Search | IOVS | ARVO Journals

Showing 1 – 20 of 31

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2018

Retrospective analysis of intravitreal incections for age related macular degeneration (ARMD) from 2012 to 2016

Gerhard Kieselbach; Claus Zehetner; martina kralinger; inga waltl; anna vavrovsky

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2395.

ARVO Annual Meeting Abstract June 2015

Systemic Counterregulatory Response of Placental Growth Factor Levels to Intravitreal Aflibercept Therapy

Claus Zehetner; Martina T Kralinger; Martin Stattin; Rudolf Kirchmair; Nikolaos Bechrakis; Gerhard Kieselbach

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4596.

Retina May 2015

Systemic Counterregulatory Response of Placental Growth Factor Levels to Intravitreal Aflibercept Therapy

PDF

Claus Zehetner; Nikolaos E. Bechrakis; Martin Stattin; Rudolf Kirchmair; Hanno Ulmer; Martina T. Kralinger; Gerhard F. Kieselbach
TAGS: aflibercept, placenta growth factor, up-regulation (physiology), vascular endothelial growth factor a, vascular endothelial growth factor b, bevacizumab, ranibizumab, cytokine
Invest. Ophthalmol. Vis. Sci.. 2015; 56(5):3279-3286. https://doi.org/10.1167/iovs.15-16686

ARVO Annual Meeting Abstract April 2014

VEGF Plasma levels after intravitreal injection of aflibercept and ranibizumab

Martina T Kralinger; Claus Zehetner; Inga Waltl; Rudolf Kirchmayr; Gerhard F. Kieselbach

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4965.

ARVO Annual Meeting Abstract April 2014

Plasma levels of PDGF-B in Patients with Neovascular AMD

Gerhard F. Kieselbach; Claus Zehetner; Rudolf Kirchmayr; Martina T Kralinger

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):582.

Retina January 2014

Systemic Upregulation of PDGF-B in Patients With Neovascular AMD

PDF

Claus Zehetner; Rudolf Kirchmair; Sabrina B. Neururer; Martina T. Kralinger; Nikolaos E. Bechrakis; Gerhard F. Kieselbach
TAGS: exudative age-related macular degeneration, platelet-derived growth factor, vascular endothelial growth factor a, up-regulation (physiology), plasma
Invest. Ophthalmol. Vis. Sci.. 2014; 55(1):337-344. https://doi.org/10.1167/iovs.13-12978

ARVO Annual Meeting Abstract March 2012

Visual Acuity after 3 Intial Injections of Intravitreal Ranibizumab in the Management of Diabetic Macular Edema

Claus Zehetner; Martina T. Kralinger; Gerhard F. Kieselbach

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):348.

ARVO Annual Meeting Abstract March 2012

Correlation of visual acuity and number of treatments with Intravitreal Injection of Bevacizumab in Patients with ARMD

Martina T. Kralinger; Katharina Hoeglinger; Claus Zehetner; Gerhard F. Kieselbach

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2916.

ARVO Annual Meeting Abstract March 2012

Vascular Endothelial Growth Factor in Plasma of Patients with ARMD after Intravitreal Injection of Bevacizumab, Ranibizumab and Pegaptanib

Gerhard F. Kieselbach; Claus Zehtner; Martina T. Kralinger; Rudolf Kirchmair

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2966.

ARVO Annual Meeting Abstract April 2011

Long Term Stability After Implantation Of Single-piece Toric Intraocular Lenses

Gerhard F. Kieselbach; Martina Kralinger; Josef Troger

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4730.

ARVO Annual Meeting Abstract April 2011

Posterior Capsule Opacification In Acri.Lyc35a Versus AcrisofSA60at

Martina T. Kralinger; Aleksandra Rogic; Josef Troger; Gerhard F. Kieselbach

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):6206.

ARVO Annual Meeting Abstract April 2010

Longtime Visual Acuity After Combined Treatment for Central Retinal Vein Occlusion (crvo) and Branch Retinal Vein Occlusion (brvo)

G. Kieselbach; T. Egger; M. T. Kralinger

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):3583.

ARVO Annual Meeting Abstract April 2009

Vip, Pacap-38, Bdnf and Adnp in Nmda-Induced Excitotoxicity in the Rat Retina

J. Troger; B. Teuchner; A. Amberger; J. Nemeth; E. Schmid; G. Kieselbach; M. Kralinger; N. Bechrakis

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):89.

ARVO Annual Meeting Abstract April 2009

Toric Lens Implantation in Cataract Surgery

M. T. Kralinger; F. Sprenger; G. Kieselbach

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):1159.

ARVO Annual Meeting Abstract April 2009

Retrospective Evaluation of Transconjunctival 23g Vitrectomy in Retinal Detachment in 12 Eyes

G. Kieselbach; M. Strasser; M. Kralinger

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):3180.

ARVO Annual Meeting Abstract May 2008

Substance P and Secretoneurin in vitreous Aspirates of Patients With Various Vitreoretinal Diseases

K. Lorenz; J. Troger; R. Fischer-Colbrie; B. Kremser; E. Schmid; M. Kralinger; B. Teuchner; G. Kieselbach

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):5219.

ARVO Annual Meeting Abstract May 2008

Long Term Evaluation of 108 Eyes With Vitrectomy for Uncomplicated Retinal Detachment

G. Kieselbach; M. Erlacher; L. Harasztos; M. Kralinger

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):5237.

ARVO Annual Meeting Abstract May 2008

Efficacy of Lucentis, Macugen and Avastin in Neovascular AMD: 12 Months Results

M. T. Kralinger; C. Zehetner; J. Troger; G. F. Kieselbach

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):307.

ARVO Annual Meeting Abstract May 2007

Effects of Intravitreal Ranibizumab on Visual Acuity, Reading Ability and Quality of Life

G. Kieselbach; M. Mittendorfer; C. Kunze; B. Kremser; M. Kralinger

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):1793.

ARVO Annual Meeting Abstract May 2007

Is Loaded Silicone Oil Feasible in the Treatment of Proliferative Vitreoretinopathy? First Results From Austrian Clinical Multicentre Study

M. T. Kralinger; U. Stolba; M. Velikay; S. Egger; S. Binder; A. Wedrich; A. Haas; J.-M. P. Parel; G. F. Kieselbach

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):5780.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Retrospective analysis of intravitreal incections for age related macular degeneration (ARMD) from 2012 to 2016

Systemic Counterregulatory Response of Placental Growth Factor Levels to Intravitreal Aflibercept Therapy

Systemic Counterregulatory Response of Placental Growth Factor Levels to Intravitreal Aflibercept Therapy

VEGF Plasma levels after intravitreal injection of aflibercept and ranibizumab

Plasma levels of PDGF-B in Patients with Neovascular AMD

Systemic Upregulation of PDGF-B in Patients With Neovascular AMD

Visual Acuity after 3 Intial Injections of Intravitreal Ranibizumab in the Management of Diabetic Macular Edema

Correlation of visual acuity and number of treatments with Intravitreal Injection of Bevacizumab in Patients with ARMD

Vascular Endothelial Growth Factor in Plasma of Patients with ARMD after Intravitreal Injection of Bevacizumab, Ranibizumab and Pegaptanib

Long Term Stability After Implantation Of Single-piece Toric Intraocular Lenses

Posterior Capsule Opacification In Acri.Lyc35a Versus AcrisofSA60at

Longtime Visual Acuity After Combined Treatment for Central Retinal Vein Occlusion (crvo) and Branch Retinal Vein Occlusion (brvo)

Vip, Pacap-38, Bdnf and Adnp in Nmda-Induced Excitotoxicity in the Rat Retina

Toric Lens Implantation in Cataract Surgery

Retrospective Evaluation of Transconjunctival 23g Vitrectomy in Retinal Detachment in 12 Eyes

Substance P and Secretoneurin in vitreous Aspirates of Patients With Various Vitreoretinal Diseases

Long Term Evaluation of 108 Eyes With Vitrectomy for Uncomplicated Retinal Detachment

Efficacy of Lucentis, Macugen and Avastin in Neovascular AMD: 12 Months Results

Effects of Intravitreal Ranibizumab on Visual Acuity, Reading Ability and Quality of Life

Is Loaded Silicone Oil Feasible in the Treatment of Proliferative Vitreoretinopathy? First Results From Austrian Clinical Multicentre Study

To View More...

You must be signed into an individual account to use this feature.